Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NZX
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

Pacific Edge Ltd

+ Add to Watchlist

PEB:NZ

0.740 NZD 0.0000.00%

As of 01:31:40 ET on 05/05/2015.

Snapshot for Pacific Edge Ltd (PEB)

Open: - Day's Range: - Volume: 1,059,576
Previous Close: 0.740 52wk Range: 0.620 - 1.120 1-Yr Rtn: -32.73%

Stock Chart for PEB

No chart data available.
  • PEB:NZ 0.740
  • 1D
  • 1M
  • 1Y
0.740
Interactive PEB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PEB

Current P/E Ratio (ttm) -
Estimated P/E(03/2015) -
Relative P/E vs. NZSE -
Earnings Per Share (NZD) (ttm) -0.0326
Est. EPS (NZD) (03/2015) -0.0280
Est. PEG Ratio -
Market Cap (M NZD) 235.78
Shares Outstanding (M) 318.62
30 Day Average Volume 215,903
Price/Book (mrq) 13.8334
Price/Sale (ttm) 204.1414
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/28/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PEB

  • Revenue
  • Net Income (M/NZD)
  • Profit Margin (%)

Company Profile & Key Executives for PEB

Pacific Edge is a biomedical company specialising in the discovery and commercialisation of diagnostic and prognostic technology for the early detection and monitoring of cancer. The Company has completed successful trials in bladder cancer detection and colorectal cancer prognosis.

David DarlingChief Executive OfficerKate RankinChief Financial Officer
Jimmy SuttieChief Operating OfficerParry GuilfordChief Scientific Officer
More Company Profile & Key Executives for PEB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil